Description
The increasing resistance of microorganisms to drugs is one of the most serious threats to global health. Scope Fluidics responds to this challenge with an innovative system which makes it possible to gain full knowledge of resistance mechanisms and the sensitivity of bacteria to all available antibiotics.
The results of this work make it possible to implement effective therapy in patients, reduce complications after infections and reduce treatment and hospitalisation costs.
BacterOMIC takes antibiotic susceptibility testing (AST) to the next level by offering quantitative assessment of all clinically relevant antibiotics and identification of synergistic antibiotic pairs.
